Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Jun 2021 for Therapeutics Acquisition Corp., €1.8M. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Peter Kolchinsky: trading record in brief
Peter Kolchinsky, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in POINT Biopharma Global Inc. and Forma Therapeutics Holdings, Inc. Over a trading history stretching from 17 June 2021 to 29 June 2021, the count stands at 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 30 June 2021, reports a share grant of €1.8M in POINT Biopharma Global Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peter Kolchinsky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
209,100 shares@ US$10.0019.1% of flowCommon StockSEC:0001104659-21-087618:0
889,218 shares@ US$10.0080.9% of flowCommon StockSEC:0001104659-21-085291:0
2,750 shares0Common StockSEC:0000899243-21-025088:0
3 of 3 declarations
